09/18/16  Portland, Ore.

Joshua Walker, MD, PhD (PGY4, Holman Research Pathway scholar) presented a novel prospective clinical trial of checkpoint inhibition &SBRT for HCC to the SWOG GI Working Group & SWOG Radiotherapy Comm semi-annual meetings in Chicago, fall 2016.